Testing the SureCore Plus Biopsy System for BPH
Part of Kidney & urinary clinical trials.
This trial tests a new tool called the SureCore Plus Biopsy System for taking prostate biopsies in people with BPH (enlarged prostate). It aims to see if this device works well and safely to help diagnose prostate issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have BPH (enlarged prostate) and your doctor says you need a prostate biopsy.
- You are able and willing to give your consent to participate.
- You do not have an active infection right now.
- You are not currently in another study that involves a prostate device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new biopsy needle called SUREcore to the standard needle used during prostate biopsies. It aims to see if the SUREcore needle works better or causes less discomfort.
This study compares a new prostate biopsy system/needle with the standard biopsy needle during your scheduled prostate biopsy. It looks at how well the procedure collects tissue for diagnosis and how the tissue samples compare.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
This trial tests a robot-assisted method for taking prostate biopsies using a new type of ultrasound probe. It may help men with certain high-risk features get a more precise diagnosis.
This trial is testing a new test (PROSTia) to see if it can help doctors decide when a prostate biopsy is needed for men with signs of possible prostate cancer.
This trial is testing a more personalized way to perform prostate biopsies. It's for men who have a suspicious finding on exam or imaging, or a higher PSA level, and who have had a special MRI that suggests cancer. The goal is to improve accuracy and reduce unnecessary biopsies.
Hear when a new BPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.